Mentions
Extended reach
Total likes
Video views
AI synopsis
The collection reflects a cautious and investigative tone, with someone questioning the lack of attention to mitochondrial damage and sarcopenia in the publication, using phrases like 'really hope someone is monitoring' and 'very surprised no one is talking about this.' Others mention the significance of the research on high-risk groups and potential health implications, showing an understanding of the topic's importance and an interest in future research and monitoring.
Most discussions show concern and curiosity about the potential risks of muscle loss, indicating general agreement that this is an important issue.
Posts highlight specific issues like mitochondrial damage and sarcopenia, demonstrating moderate interest in the topic.
Some posters actively question current research gaps and implications, showing a moderate level of in-depth engagement.
The focus on potential health risks and the call for further monitoring suggest that these discussions recognize a meaningful impact on patient care and clinical considerations.
Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体重減少の15‐40％が除脂肪体重。G高たんぱく質の食事と筋トレの併用で筋量減少を緩和できるかも。リハ栄養ですね https://t.co/Slyqt4Yh9l
Impacto de la terapia con agonistas del receptor GLP-1 en pacientes con alto riesgo de sarcopenia #alianzametabólica https://t.co/gZf1XZ0RGd https://t.co/JDSmLeXtdx
RT @javierbutra: Impacto de la terapia con agonistas del receptor GLP-1 en pacientes con alto riesgo de sarcopenia #alianzametabólica https…
@julialmv @bhanlon15 I really hope someone is monitoring for sarcopenia/cachexia. Very surprised no one is talking about this given the mitochondrial damage data that will be forthcoming with GLP-1 drugs. Has no one looked into this? https://t.co/7r6xZQVgAb
RT @javierbutra: Impacto de la terapia con agonistas del receptor GLP-1 en pacientes con alto riesgo de sarcopenia #alianzametabólica https…
RT @HideWakabayashi: Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体…
Dr Ita Fitzgerald examines the evidence for GLP-1 receptor agonists in managing antipsychotic-induced weight gain, highlighting their role compared to other treatments like Metformin and discussing implications for…
GLP1 receptor agonists are effective for weight loss and managing chronic diseases but may cause muscle loss in high-risk groups. Strategies like high-protein diets and resistance training are essential to mitigate this…
@julialmv @bhanlon15 I really hope someone is monitoring for sarcopenia/cachexia. Very surprised no one is talking about this given the mitochondrial damage data that will be forthcoming with GLP-1 drugs. Has no one looked into this? https://t.co/7r6xZQVgAb
Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis https://www.medrxiv.org/content/10.1101/2025.05.29.25328594v1
RT @HideWakabayashi: Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体…
RT @HideWakabayashi: Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体…
RT @HideWakabayashi: Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体…
RT @HideWakabayashi: Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体…
RT @HideWakabayashi: Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体…
Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia. サルコペニアのハイリスク患者でのGLP-1受容体作動薬の総説。多い場合、総体重減少の15‐40％が除脂肪体重。G高たんぱく質の食事と筋トレの併用で筋量減少を緩和できるかも。リハ栄養ですね https://t.co/Slyqt4Yh9l
RT @javierbutra: Impacto de la terapia con agonistas del receptor GLP-1 en pacientes con alto riesgo de sarcopenia #alianzametabólica https…
RT @javierbutra: Impacto de la terapia con agonistas del receptor GLP-1 en pacientes con alto riesgo de sarcopenia #alianzametabólica https…
Impacto de la terapia con agonistas del receptor GLP-1 en pacientes con alto riesgo de sarcopenia #alianzametabólica https://t.co/gZf1XZ0RGd https://t.co/JDSmLeXtdx
2025, doi:10.1007/s13668-025-00649-w 3-New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation, June 23, 2025 ...
2025, doi:10.1007/s13668-025-00649-w 3-New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation, June 23, 2025 ...
Prenatal 4-week Fitness Series by Well Balanced PT. 2333 W 57th Street, Suite 103, Sioux Falls, SD, Unite... 1 person going ·
link: https://link.springer.com/article/10.1007/s13668-025-00649-w DOI: 10.1007/s13668-025-00649-w.
2025, doi:10.1007/s13668-025-00649-w 3-New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation, June 23, 2025 ...
2025, doi:10.1007/s13668-025-00649-w 3-New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation, June 23, 2025 ...
若W
J
DE
GC
JO
無で
岩
CL
NI
北